Navigation Links
Reportlinker Adds Global Biomaterial Market (2010 - 2015)
Date:5/9/2011

NEW YORK, May 9, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Biomaterial Market (2010 - 2015)

http://www.reportlinker.com/p0148007/Global-Biomaterial-Market-2010---2015.html

Report Description:

The global market for biomaterials is expected to reach $64.7 billion in 2015 from $25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015. In 2010, the orthopedic biomaterial market recorded revenues of $12 billion or 37.5% of the total global biomaterial market. This is mainly because of the demand generated by the increasing aging population worldwide, and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterials market is estimated to grow slowly, at a CAGR of 12.7% (2010 to 2015) because the market is relatively mature compared to other product markets. Cardiovascular biomaterial is the second-highest market, and contributed 36.1% to the global biomaterial market in 2010.

With the increase in the percentage of aging population worldwide, the number of individuals suffering from physical disability is also increasing. Baby boomers born between the years 1946 and 1964 are the major consumers of the biomaterial products. Also, more than 20% of the global population is expected to be over 60 years in 2050 and this segment of the population will be significantly high in developing countries. This increase in the aging population will drive the demand for biomaterial products.

The biomaterial market definitely holds a significant opportunity for innovators, but extensive research is required to develop new and improved products at competitive prices. Particularly in the developing countries pricing is a major deciding factor for the biomaterial markets. The other issue involves regulations that have to be streamlined. This will open more doors for the development of new and improved products, new opportunities in terms of application areas and eventually increase the market size for the products. Biomaterial products are expensive, and an improvement in performance would justify the higher pricing and also boost the market size. Major developments in the biomaterials market will be witnessed with the cooperation between the material suppliers and manufacturing companies; thus streamlining mergers and acquisitions would help the overall market. The U.S. government is expected to spend more in the medical care sector; that, in turn, could boost the market for biomaterials provided the economy revives. The effect of the current economic downturn is also felt by the companies manufacturing biomaterial products because although these companies are compensated by the health insurers, patients have delayed their scheduled procedures. However, the effect of the poor state of the economy influencing the timing of surgeries is expected to wane gradually. When that happens, companies into the biomaterials market will enjoy higher demand, leading to higher revenues.

Markets covered

This research report categorizes the biomaterials market into the following:

Biomaterial market, by products: Orthopedic, cardiovascular, wound care, gastrointestinal, urological, plastic surgery, and others

Biomaterial market, by materials: Metals, polymers, ceramics, and composites

Biomaterial market, by application: General surgery, surgical appliances and supplies, surgical and medical instruments, dental products, electro medical equipment, and other applications

The report provides market estimates and forecasts for the global biomaterial market. In addition to market sizing and forecasts, the report offers a detailed analysis of the market trends, opportunities, and the factors influencing the growth of each segment of the biomaterials market. The report also draws a competitive landscape, analyzing core competencies of major players and strategies adopted to expand their market presence.

Stakeholders

The targeted audience for this report includes:

Pharmaceutical and biotech companies

Medical devices manufacturers

Pharma-research labs

Doctors, physicians, and hospitals

Medical/Pharma associations

Retailers and super-retailers

Technology providers

Research and development (R&D) companies

Research methodology

Secondary research is carried out using proprietary databases (both paid and public), company websites, news articles, etc. The primary research involves interviews with specialists, CEO's, managers, and directors working with major market players (key industry participants) and subject matter experts from research institutes. Data and analytic output from secondary research such as markets drivers, restraints, growth opportunities, market forecasts, and others have been validated with primary research. Market size of the segments was calculated using the bottom-up approach and figures thus derived were added to yield the biomaterial market revenues, while each year's forecast is based on the analysis of industry trends.

The primary research involves interviews with specialists, CEO's, managers, and directors from major market players (key industry participants) and subject matter experts from research institutes. Data & analytic output from secondary research such as markets drivers, restraints, growth opportunities, market forecasts, and others were validated with the primary research.

Hence, market size of the segments was calculated using bottom-up approach and figures thus derived were added to yield the biomaterial market revenues; while each year's forecast is based on industry trend analysis

TABLE OF CONTENTS

EXECUTIVE SUMMARY

? MARKET OVERVIEW

1 INTRODUCTION

1.1 KEY TAKE-AWAYS

1.2 REPORT DESCRIPTION

1.3 MARKETS COVERED

1.4 STAKEHOLDERS

1.5 RESEARCH METHODOLOGY

2 SUMMARY

3 MARKET OVERVIEW

3.1 INTRODUCTION

3.2 DEFINING THE GLOBAL BIOMATERIAL MARKET

3.3 DRIVING FACTOR ANALYSIS OF GLOBAL BIOMATERIAL MARKET

3.3.1 SUPPLY SIDE DRIVERS

3.3.2 DEMAND SIDE DRIVERS

3.3.3 RESTRAINTS

3.3.4 OPPORTUNITIES

3.3.5 KEY COMPETITIVE POINTS

3.4 DRIVERS

3.4.1 NEW & IMPROVED TECHNOLOGIES

3.4.2 DEVELOPMENTS IN BIOCOMPATIBILITY SCIENCE

3.4.3 LARGE APPLICATION AREA

3.4.4 INTRODUCTION OF BIO-ABSORBABLE BIOMATERIALS

3.4.5 RISING AWARENESS

3.4.6 MEDICAL APPLICATIONS OF SYNTHETIC BIOMATERIALS

3.4.7 BIOMATERIALS HELP TREAT AGE-RELATED PROBLEMS

3.4.8 MEDICAL INSURANCE COVERAGE

3.4.9 RECENT DEVELOPMENTS IN BIOMATERIAL RESEARCH

3.4.10 INCREASING FOCUS ON PERSONAL HEALTHCARE

3.5 INHIBITORS

3.5.1 LACK OF TISSUE AVAILABILITY

3.5.2 LACK OF PROPER REIMBURSEMENT FACILITIES

3.6 OPPORTUNITIES

3.6.1 MARKET PARTICIPATION BY SMALLER COMPANIES

3.6.2 GROWING NEED FOR INTEGRATED & COMBINED MATERIALS

3.6.3 INTELLIGENT MATERIALS WITH DYNAMIC MOLECULAR FUNCTIONS

3.6.4 EMERGING PREFERENCE FOR MINIMALLY INVASIVE SURGERY

4 BIOMATERIAL MARKET – BY PRODUCTS

4.1 INTRODUCTION

4.2 ORTHOPEDIC BIOMATERIAL

4.2.1 DRIVERS

4.2.1.1 Product penetration

4.2.1.2 Increasing use of orthopedic biomaterials in spine surgery

4.2.1.3 Easy surgical procedures

4.2.2 INHIBITORS

4.2.2.1 Economic constraints

4.2.2.2 Increasing competition reduces profit margin

4.2.3 OPPORTUNITIES

4.2.3.1 Spinal treatment expected to be on the rise

4.2.4 TOP PLAYER ANALYSIS OF ORTHOPEDIC BIOMATERIAL MARKET

4.2.5 ORTHOPEDIC RECONSTRUCTIVE BIOMATERIAL

4.2.5.1 Drivers

4.2.5.1.1 Wide range of products available for specific applications

4.2.5.1.2 Development of new materials with improved properties

4.2.5.2 Inhibitors & opportunities

4.2.5.3 Top players analysis in orthopedic reconstructive market

4.2.5.4 Artificial knee

4.2.5.4.1 Constraint implants

4.2.5.4.2 Non-constraint implants

4.2.5.4.3 Semi-constraint implants

4.2.5.5 Artificial hip

4.2.5.5.1 Cemented prostheses biomaterial market

4.2.5.5.2 Uncemented prostheses biomaterial market

4.2.6 ORTHOBIOLOGICS BIOMATERIAL

4.2.6.1 Top player analysis of orthobiologics biomaterial market

4.2.6.2 Machined bone allografts

4.2.6.3 Demineralized bone matrix (DBM)

4.2.6.4 Bone morphogenic protein (BMP)

4.2.6.5 Synthetic bone substitute

4.2.6.6 Non-proprietary allografts

4.2.6.7 Platelet concentrates

4.2.7 BONE CEMENT

4.2.7.1 Drivers

4.2.7.1.1 Bone cements ease lesions & can be used with antibiotics

4.2.7.2 Inhibitors & opportunities

4.2.7.3 Top player analysis of bone cement orthopedic biomaterial market

4.2.8 TRAUMA BIOMATERIAL

4.2.8.1 Drivers

4.2.8.1.1 Sports injuries & other accidents

4.2.8.1.2 Plate & screw systems drive overall market growth

4.2.8.2 Top players analysis of trauma orthopedic biomaterial market

4.2.9 SPINAL BIOMATERIAL

4.2.9.1 Drivers

4.2.9.1.1 Spinal treatment for younger patients on the rise

4.2.9.1.2 Motion - preserving devices drive growth

4.2.9.2 Inhibitors & Opportunities

4.2.9.2.1 Reimbursement challenges restrain growth

4.2.9.2.2 Technology & product development provide scope for improvement

4.2.9.3 Top player analysis of spine orthopedic biomaterial market

4.2.9.4 Cervical biomaterials

4.2.9.5 Lumbar biomaterials

4.2.10 SPORTS MEDICINE

4.2.10.1 Drivers

4.2.10.2 Top player analysis of sports medicine orthopedic biomaterial market

4.2.11 DENTAL ORTHOPEDICS

4.2.11.1 Drivers

4.2.11.2 Inhibitors & Opportunities

4.2.11.3 Top player analysis of dental orthopedic biomaterial market

4.2.11.4 Dental bone grafts and substitutes

4.2.11.4.1 Dental allograft

4.2.11.4.2 Dental synthetic

4.2.11.4.3 Dental xenograft

4.2.11.5 Dental membranes

4.2.11.6 Tissue regeneration

4.3 CARDIOVASCULAR BIOMATERIAL

4.3.1 DRIVERS

4.3.1.1 Biomaterials enhance cardiovascular treatment

4.3.1.2 Rising number of obesity cases

4.3.1.3 Increase in thrombosis and heart failure treatments

4.3.1.4 Vascular surgery market is growing with the use of biomaterials

4.3.2 INHIBITORS & OPPORTUNITIES

4.3.3 TOP PLAYER ANALYSIS OF CARDIOVASCULAR BIOMATERIALS MARKET

4.3.4 CARDIAC STENTS

4.3.4.1 Top player analysis of cardiac stents biomaterial market

4.3.5 PERIPHERAL VASCULAR GRAFTS

4.3.6 VASCULAR ACCESS DEVICES

4.3.6.1 Drivers & Inhibitors

4.3.6.2 Top player analysis of vascular access devices biomaterial market

4.3.7 CARDIAC PACEMAKER

4.3.7.1 Top player analysis of cardiac pacemaker cardiovascular biomaterial market

4.3.8 ARTIFICIAL HEART VALVE

4.3.8.1 Top player analysis of artificial heart valve cardiovascular biomaterial market

4.3.9 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

4.3.9.1 Top player analysis of implantable cardioverter defibrillator cardiovascular biomaterial market

4.4 WOUND CARE BIOMATERIAL

4.4.1 DRIVERS

4.4.1.1 Multiple advantages over conventional wound care products

4.4.1.2 Supports healing process of the skin

4.4.1.3 Gel-based products accelerate wound healing

4.4.1.4 Prevention of bacterial colonization on sutures

4.4.1.5 Reduction in the cost of hospitalization

4.4.1.6 Eliminates frequent change of dressings

4.4.1.7 Increase in diabetes foot ulcer

4.4.2 INHIBITORS

4.4.2.1 Slow rate of product development

4.4.3 OPPORTUNITIES

4.4.3.1 Increase in penetration of negative pressure wound

4.4.3.2 Introduction of more efficient and cost effective therapies

4.4.3.3 Use of natural polymer biomaterials for stability in treatment

4.4.4 TOP PLAYER ANALYSIS OF WOUND CARE BIOMATERIAL MARKET

4.4.5 SURGICAL HEMOSTATS

4.4.5.1 Drivers

4.4.5.1.1 Surgical hemostats control bleeding

4.4.5.1.2 Reduces need for frequent blood transfusions

4.4.5.2 Top player analysis of surgical hemostats market

4.4.5.3 Thrombin-based hemostats

4.4.5.4 Oxidized regenerated cellulose-based hemostats

4.4.5.5 Collagen-based hemostats

4.4.5.6 Autologous-based hemostats

4.4.5.7 Polysaccharide based hemostats

4.4.5.8 Gelatin-based hemostats

4.4.5.9 Combination hemostats

4.4.6 SKIN SUBSTITUTE

4.4.7 INTERNAL TISSUE SEALANT

4.4.7.1 Drivers

4.4.7.1.1 Technological advances

4.4.7.1.2 Wide range of applications & features

4.4.7.1.3 Faster healing

4.4.7.2 Top player analysis of internal tissue sealant wound care biomaterial market

4.4.7.3 Fibrin-based sealants

4.4.7.4 Synthetic-based sealant

4.4.8 ADHESION BARRIERS

4.4.8.1 Drivers

4.4.8.2 Inhibitors & Opportunities

4.4.8.3 Top player analysis of adhesion prevention wound care biomaterial market

4.4.8.4 Films

4.4.8.5 Gels

4.5 PLASTIC SURGERY BIOMATERIAL

4.5.1 DRIVERS

4.5.1.1 Baby boomers to boost market growth

4.5.1.2 More surgeons are moving towards plastic surgery from reconstructive procedures

4.5.1.3 Cultural factors boost market growth

4.5.2 INHIBITORS & OPPORTUNITIES

4.5.2.1 Difficulties in treating craniofacial trauma

4.5.2.2 Male population untapped for facial surgeries

4.5.3 TOP PLAYER ANALYSIS OF PLASTIC SURGERY BIOMATERIAL MARKET

4.5.4 FACIAL IMPLANTS

4.5.4.1 Drivers

4.5.4.1.1 Iraq war increased demand for facial implants

4.5.4.1.2 Faster recovery

4.5.4.2 Inhibitors & Opportunities

4.5.4.3 Top player analysis of facial implants biomaterial market

4.5.5 INJECTABLE FILLERS

4.5.5.1 Drivers

4.5.5.1.1 Increase in awareness of skin care

4.5.5.1.2 Permanent results can be achieved using fillers

4.5.5.2 Inhibitors & Opportunities

4.5.5.2.1 Allergy

4.5.5.3 Top player analysis of injectable fillers biomaterial market

4.5.6 BREAST IMPLANTS

4.5.6.1 Drivers

4.5.6.1.1 Availability of more refined procedures

4.5.6.2 Inhibitors & Opportunities

4.5.6.3 Top player analysis of breast implants biomaterial market

4.5.6.4 Silicone gel implants

4.5.6.5 Saline-filled implants

4.6 UROLOGICAL BIOMATERIAL

4.6.1 DRIVERS

4.6.1.1 Availability of biodegradable materials for treatment

4.6.1.2 Development of scaffolds for treatment of several disorders

4.6.2 INHIBITORS & OPPORTUNITIES

4.6.3 TOP PLAYER ANALYSIS OF UROLOGICAL BIOMATERIAL MARKET

4.6.4 STENTS

4.6.4.1 Drivers

4.6.4.1.1 Stents are used in short duration treatment

4.6.4.1.2 Growing population

4.6.4.2 Inhibitors & Opportunities

4.6.5 CATHETERS

4.6.5.1 Drivers & Inhibitors

4.6.5.1.1 Developments in catheter design increased applicability

4.6.5.1.2 Prolonged use of catheters may lead to cancer

4.6.5.2 Opportunities

4.6.5.2.1 Use of biomaterials in catheters eliminates certain disadvantages

4.6.5.2.2 Biocompatibility of chemicals can be improved in catheters

4.6.5.3 Dialysis catheter

4.6.5.3.1 Top player analysis of dialysis catheter market

4.6.5.3.2 Hemodialysis catheter

4.6.5.3.3 Peritonial catheter

4.6.5.4 Urinary catheter

4.7 GASTROINTESTINAL BIOMATERIAL

4.7.1 DRIVERS

4.7.1.1 Increasing incidence of gastrointestinal diseases

4.7.1.2 FDA approval for OTC gastrointestinal drugs

4.7.2 INHIBITORS & OPPORTUNITIES

4.7.3 TOP PLAYER ANALYSIS OF GASTROINTESTINAL BIOMATERIAL MARKET

5 BIOMATERIAL MARKET – BY TYPES

5.1 INTRODUCTION

5.2 METALS

5.2.1 DRIVERS

5.2.1.1 Balancing act of metallic biomaterials

5.2.1.2 Improved properties of metallic biomaterials

5.2.2 INHIBITORS

5.2.2.1 Corrosion may occur in the implant

5.2.3 OPPORTUNITIES

5.2.3.1 Improvement in corrosion resistance

5.2.3.2 Introduction of new alloys

5.2.4 TOP PLAYER ANALYSIS OF METALLIC BIOMATERIAL MARKET

5.2.5 PURE FORM METALS

5.2.5.1 Titanium

5.2.5.2 Platinum

5.2.5.3 Silver

5.2.5.4 Gold

5.2.6 ALLOYS

5.2.6.1 Drivers

5.2.6.1.1 Easy availability of ore for biomaterials manufacture

5.2.6.1.2 Can be sterilized easily

5.2.6.2 Inhibitors & Opportunities

5.2.6.3 Top player analysis of alloy biomaterial market

5.2.6.4 High carbon cobalt chromium alloy

5.3 CERAMICS

5.3.1 TOP PLAYER ANALYSIS OF CERAMICS BIOMATERIAL MARKET

5.3.2 BIOINERT CERAMICS

5.3.2.1 Drivers

5.3.2.1.1 Compatibility with high-strength applications

5.3.2.1.2 High chemical stability

5.3.2.2 Inhibitors & Opportunities

5.3.2.3 Alumina

5.3.2.4 Zirconia ceramic

5.3.2.5 Other bioinert ceramics market

5.3.3 BIOACTIVE CERAMICS

5.3.3.1 Drivers

5.3.3.1.1 Ceramics aid bone formation

5.3.3.2 Inhibitors & Opportunities

5.3.3.3 Bioglass

5.3.3.4 Other bioactive ceramics market

5.3.4 BIODEGRADABLE CERAMICS

5.3.4.1 Hydroxyapetite

5.3.4.2 Others biodegradable biomaterial market

5.4 POLYMERS

5.4.1 DRIVERS

5.4.1.1 Naturally biodegradable

5.4.1.2 Compatibility in imaging

5.4.2 INHIBITORS & OPPORTUNITIES

5.4.3 TOP PLAYER ANALYSIS OF POLYMER BIOMATERIAL MARKET

5.4.4 NATURAL POLYMERS

5.4.4.1 Drivers

5.4.4.1.1 Safe to use

5.4.4.1.2 Work at a molecular level

5.4.4.2 Inhibitors & Opportunities

5.4.4.3 Collagen-based biomaterials

5.4.4.3.1 Drivers

5.4.4.4 Chitosan

5.4.4.5 Alginate

5.4.4.6 Others natural polymers

5.4.5 SYNTHETIC POLYMER BIOMATERIAL

5.4.5.1 Hyaluronic acid (HA)

5.4.5.2 PLA/PGA (poly lactic acid/Poly lactic-co glycolic acid)

5.4.5.3 PTFE (polytetrafluoroethylene)

5.4.5.4 Other synthetic polymers

6 BIOMATERIAL MARKET – BY APPLICATIONS

6.1 INTRODUCTION

6.2 SURGICAL APPLIANCES & SUPPLIES

6.2.1 DRIVERS

6.2.1.1 Advanced materials for surgical appliances

6.2.1.2 Advances in orthopedic & prosthetic applications

6.2.1.3 Increased healthcare spending in developed countries

6.2.1.4 No side effects

6.2.1.5 Biomaterials accelerate natural phenomena

6.2.2 MARKET INHIBITORS

6.2.2.1 Lack of capital investment in R&D

6.2.2.2 Slow approval process

6.2.3 OPPORTUNITIES

6.2.3.1 Increase in export opportunities

6.2.3.2 Future development of artificial organs

6.2.3.3 Treatment for sleep disorders

6.3 SURGICAL & MEDICAL INSTRUMENTS

6.3.1 DRIVERS

6.3.1.1 Innovations in surgical instruments

6.3.1.2 Availability of cheap surgical instruments

6.3.2 INHIBITORS & OPPORTUNITIES

6.4 DRUG DELIVERY

6.4.1 DRIVERS

6.4.1.1 Enabling properties of biomaterials

6.4.1.2 Most biomaterials are bio-absorbable

6.4.1.3 Development of quick & effective methods

6.4.2 INHIBITORS & OPPORTUNITIES

6.4.2.1 Adverse side effects from certain biomaterials inhibit growth

6.4.2.2 Nano biomaterials for controlled drug delivery

6.5 GENERAL SURGERY

6.5.1 DRIVERS

6.5.1.1 Synthetic biomaterials make suturing easier

6.5.1.2 Biomaterials meet the stringent requirements of surgeons

6.5.1.3 Biomaterials are used as adhesion prevention materials

6.5.2 INHIBITORS & OPPORTUNITIES

6.6 ELECTRO-MEDICAL EQUIPMENT

6.6.1 DRIVERS

6.6.1.1 Significant increase in patient-base

6.6.1.2 Demand for efficient procedures and economies of scale

6.6.2 INHIBITORS & OPPORTUNITIES

6.7 DENTAL PRODUCTS

6.7.1 DRIVERS

6.7.1.1 Biomaterials have wide range of dental applications

6.7.1.2 Risk of dental disease is set to increase

6.7.1.3 Improvement in polymers for dental applications

6.7.2 INHIBITORS & OPPORTUNITIES

6.8 OTHER APPLICATIONS

7 GEOGRAPHIC ANALYSIS

7.1 INTRODUCTION

7.2 U.S.

7.3 EUROPE

7.4 ASIA

8 COMPANY PROFILES

8.1 3DM INC.

8.1.1 OVERVIEW

8.1.2 PRODUCTS & SERVICES

8.1.3 STRATEGY

8.1.4 DEVELOPMENTS

8.2 ADVANSOURCE BIOMATERIALS CORP

8.2.1 OVERVIEW

8.2.2 FINANCIALS

8.2.3 PRODUCTS & SERVICES

8.2.4 STRATEGY

8.2.5 DEVELOPMENTS

8.3 ALLERGAN INC.

8.3.1 OVERVIEW

8.3.2 FINANCIALS

8.3.3 PRODUCTS & SERVICES

8.3.4 STRATEGY

8.3.5 DEVELOPMENTS

8.4 ALLOSOURCE INC.

8.4.1 OVERVIEW

8.4.2 PRODUCTS & SERVICES

8.4.3 STRATEGY

8.4.4 DEVELOPMENTS

8.5 ALPHATEC SPINE INC.

8.5.1 OVERVIEW

8.5.2 FINANCIALS

8.5.3 PRODUCTS & SERVICES

8.5.4 STRATEGY

8.5.5 DEVELOPMENTS

8.6 AMEDICA CORPORATION

8.6.1 OVERVIEW

8.6.2 PRODUCTS & SERVICES

8.6.3 STRATEGY

8.6.4 DEVELOPMENTS

8.7 ANGIOTECH PHARMACEUTICALS INC.

8.7.1 OVERVIEW

8.7.2 FINANCIALS

8.7.3 PRODUCTS & SERVICES

8.7.4 STRATEGY

8.7.5 DEVELOPMENTS

8.8 ARTIMPLANT AB

8.8.1 OVERVIEW

8.8.2 PRODUCTS & SERVICES

8.8.3 STRATEGY

8.8.4 DEVELOPMENTS

8.9 BAXTER INTERNATIONAL INC.

8.9.1 OVERVIEW

8.9.2 FINANCIALS

8.9.3 PRODUCTS & SERVICES

8.9.4 STRATEGY

8.9.5 DEVELOPMENTS

8.10 BIO SYNTECH CANADA INC.

8.10.1 OVERVIEW

8.10.2 PRODUCTS & SERVICES

8.11 BIOCOMPOSITES LTD.

8.11.1 OVERVIEW

8.11.2 PRODUCTS & SERVICES

8.11.3 STRATEGY

8.11.4 DEVELOPMENTS

8.12 BIOMET INC.

8.12.1 OVERVIEW

8.12.2 FINANCIALS

8.12.3 PRODUCTS & SERVICES

8.12.4 STRATEGY

8.12.5 DEVELOPMENTS

8.13 BOSTON SCIENTIFIC CORPORATION

8.13.1 OVERVIEW

8.13.2 FINANCIALS

8.13.3 PRODUCTS & SERVICES

8.13.4 STRATEGY

8.13.5 DEVELOPMENTS

8.14 COLLAGEN MATRIX INC.

8.14.1 OVERVIEW

8.14.2 PRODUCTS & SERVICES

8.14.3 STRATEGY

8.14.4 DEVELOPMENTS

8.15 COLLPLANT LTD.

8.15.1 OVERVIEW

8.15.2 PRODUCTS & SERVICES

8.15.3 STRATEGY

8.15.4 DEVELOPMENTS

8.16 COVALON TECHNOLOGIES LTD.

8.16.1 OVERVIEW

8.16.2 FINANCIALS

8.16.3 PRODUCTS & SERVICES

8.16.4 STRATEGY

8.16.5 DEVELOPMENTS

8.17 CRYOLIFE INC.

8.17.1 OVERVIEW

8.17.2 FINANCIALS

8.17.3 PRODUCTS & SERVICES

8.17.4 STRATEGY

8.17.5 DEVELOPMENTS

8.18 DEPUY ORTHOPEDICS INC.

8.18.1 OVERVIEW

8.18.2 FINANCIALS

8.18.3 PRODUCTS & SERVICES

8.18.4 STRATEGY

8.18.5 DEVELOPMENTS

8.19 ETEX CORPORATION

8.19.1 OVERVIEW

8.19.2 PRODUCTS & SERVICES

8.20 INTEGRA LIFE SCIENCES HOLDINGS CORP

8.20.1 OVERVIEW

8.20.2 FINANCIALS

8.20.3 PRODUCTS & SERVICES

8.20.4 STRATEGY

8.20.5 DEVELOPMENTS

8.21 INVIBIO LIMITED

8.21.1 OVERVIEW

8.21.2 PRODUCTS & SERVICES

8.21.3 STRATEGY

8.21.4 DEVELOPMENTS

8.22 MEDTRONIC INC.

8.22.1 OVERVIEW

8.22.2 FINANCIALS

8.22.3 PRODUCTS & SERVICES

8.22.4 STRATEGY

8.22.5 DEVELOPMENTS

8.23 ORTHOVITA INC.

8.23.1 OVERVIEW

8.23.2 FINANCIALS

8.23.3 PRODUCTS & SERVICES

8.23.4 STRATEGY

8.23.5 DEVELOPMENTS

8.24 RTI BIOLOGICS INC.

8.24.1 OVERVIEW

8.24.2 FINANCIALS

8.24.3 PRODUCTS & SERVICES

8.24.4 STRATEGY

8.24.5 DEVELOPMENTS

8.25 SMITH & NEPHEW PLC

8.25.1 OVERVIEW

8.25.2 FINANCIALS

8.25.3 PRODUCTS & SERVICES

8.25.4 STRATEGY

8.25.5 DEVELOPMENTS

8.26 ST. JUDE MEDICAL INC.

8.26.1 OVERVIEW

8.26.2 FINANCIALS

8.26.3 PRODUCTS & SERVICES

8.26.4 STRATEGY

8.26.5 DEVELOPMENTS

8.27 STRYKER CORPORATION

8.27.1 OVERVIEW

8.27.2 FINANCIALS

8.27.3 PRODUCTS & SERVICES

8.27.4 STRATEGY

8.27.5 DEVELOPMENTS

8.28 SYNTHES INC.

8.28.1 OVERVIEW

8.28.2 FINANCIALS

8.28.3 PRODUCTS & SERVICES

8.28.4 STRATEGY

8.28.5 DEVELOPMENTS

8.29 WRIGHT MEDICAL GROUP, INC.

8.29.1 OVERVIEW

8.29.2 FINANCIALS

8.29.3 PRODUCTS & SERVICES

8.29.4 STRATEGY

8.29.5 DEVELOPMENTS

8.30 ZIMMER HOLDING, INC.

8.30.1 OVERVIEW

8.30.2 FINANCIALS

8.30.3 PRODUCTS & SERVICES

8.30.4 STRATEGY

8.30.5 DEVELOPMENTS

APPENDIX

? PRODUCTS

? U.S. PATENTS

? EUROPE PATENTS

? JAPAN PATENTS

? BIOMATERIALS

? U.S. PATENTS

? EUROPE PATENTS

? JAPAN PATENTS

LIST OF TABLES

1 GLOBAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

2 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

3 ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

4 GLOBAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

5 MAJOR PLAYERS & DEVELOPMENTS

6 GLOBAL RECONSTRUCTIVE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

7 RECONSTRUCTIVE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

8 GLOBAL RECONSTRUCTIVE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

9 MAJOR PLAYERS & DEVELOPMENTS

10 GLOBAL ARTIFICIAL KNEE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

11 ARTIFICIAL KNEE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

12 CONSTRAINT IMPLANTS ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

13 NON-CONSTRAINT IMPLANT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

14 SEMI-CONSTRAINT IMPLANTS ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

15 GLOBAL ARTIFICIAL HIP ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

16 ARTIFICIAL HIP ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

17 CEMENTED PROSTHESES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

18 UNCEMENTED PROSTHESES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

19 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

20 ORTHOBIOLOGICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

21 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

22 MAJOR PLAYERS & DEVELOPMENTS

23 MACHINE BONE ALLOGRAFT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

24 DBM ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

25 BMP ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

26 SYNTHETIC BONE SUBSTITUTE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

27 NON-PROPRIETARY ALLOGRAFTS ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

28 PLATELET CONCENTRATES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

29 BONE CEMENT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

30 MAJOR PLAYERS & DEVELOPMENTS

31 GLOBAL TRAUMA ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

32 TRAUMA ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

33 GLOBAL TRAUMA ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

34 MAJOR PLAYERS & PRODUCT DEVELOPMENT

35 GLOBAL SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

36 SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

37 GLOBAL SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

38 MAJOR PLAYERS & DEVELOPMENTS

39 GLOBAL CERVICAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

40 CERVICAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

41 GLOBAL LUMBAR ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

42 LUMBAR SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

43 SPORTS MEDICINE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

44 MAJOR PLAYERS & DEVELOPMENTS

45 GLOBAL DENTAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

46 DENTAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

47 GLOBAL DENTAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

48 MAJOR PLAYERS & DEVELOPMENTS

49 GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

50 DENTAL BONE GRAFTS & SUBSTITUTES ORTHOPEDIC BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

51 DENTAL ALLOGRAFT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

52 DENTAL SYNTHETIC ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

53 DENTAL XENOGRAFT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

54 DENTAL MEMBRANES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

55 TISSUE REGENERATION ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

56 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

57 CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

58 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

59 MAJOR PLAYERS & PRODUCT DEVELOPMENTS

60 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

61 CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

62 MAJOR PLAYERS & PRODUCT DEVELOPMENTS

63 PERIPHERAL VASCULAR GRAFTS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

64 GLOBAL VASCULAR ACCESS DEVICE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

65 VASCULAR ACCESS DEVICE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

66 MAJOR PLAYERS & DEVELOPMENTS

67 CARDIAC PACEMAKER CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

68 MAJOR PLAYERS & DEVELOPMENTS

69 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

70 ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

71 MAJOR PLAYERS & DEVELOPMENTS

72 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

73 MAJOR PLAYERS & DEVELOPMENTS

74 GLOBAL WOUND CARE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

75 WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

76 GLOBAL WOUND CARE BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

77 MAJOR PLAYERS & DEVELOPMENTS

78 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

79 SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

80 MAJOR PLAYERS & DEVELOPMENTS

81 THROMBIN-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

82 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

83 COLLAGEN-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

84 AUTOLOGOUS-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

85 POLYSACCHARIDE-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

86 GELATIN-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

87 COMBINATION-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

88 SKIN SUBSTITUTE WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

89 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

90 INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

91 MAJOR PLAYERS & DEVELOPMENTS

92 FIBRIN-BASED SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

93 SYNTHETIC-BASED SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

94 GLOBAL ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

95 ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

96 MAJOR PLAYERS & DEVELOPMENTS

97 FILMS ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

98 GELS ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

99 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY PRODUCTS 2008 – 2015 ($MILLION)

100 PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

101 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

102 MAJOR PLAYERS & DEVELOPMENT

103 FACIAL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

104 MAJOR PLAYERS & DEVELOPMENTS

105 GLOBAL INJECTABLE FILLERS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

106 MAJOR PLAYERS & DEVELOPMENTS

107 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

108 BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

109 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

110 MAJOR PLAYERS & DEVELOPMENTS

111 SILICONE GEL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

112 SALINE-FILLED IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

113 GLOBAL UROLOGICAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

114 UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

115 GLOBAL UROLOGICAL BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 – 2015 ($MILLION)

116 MAJOR PLAYERS & DEVELOPMENTS

117 UROLOGICAL STENTS MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

118 GLOBAL UROLOGICAL CATHETERS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

119 UROLOGICAL CATHETERS MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

120 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

121 DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

122 MAJOR PLAYERS & DEVELOPMENTS

123 EMODIALYSIS UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

124 PERITONEAL CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

125 GLOBAL URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)

126 URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

127 GASTROINTESTINAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)

128 MAJOR PLAYERS & DEVELOPMENTS

129 GLOBAL BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)

130 GLOBAL METALS BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)

131 MAJOR PLAYERS & DEVELOPMENTS

132 GLOBAL PURE FORM METALS BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)

133 GLOBAL ALLOY BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)

134 MAJOR PLAYERS & DEVELOPMENTS

135 GLOBAL CERAMICS BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)

136 MAJOR PLAYERS & DEVELOPMENT

137 TECHNOLOGICAL ADVANCEMENTS IN CERAMICS

138 GLOBAL BIOINERT CERAMICS MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)

139 GLOBAL BIOACTIVE CERAMICS MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)

140 GLOBAL BIODEGRADABLE CERAMICS MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)

141 GLOBAL POLYMER BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)

142

To order this report:

: Global Biomaterial Market (2010 - 2015)

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Reportlinker Adds Genetics Reports Bundle
2. Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
3. Reportlinker Adds Biomarkers: Technologies and Global Markets
4. Reportlinker Adds Medical Enzymes: Technologies and Global Markets
5. Reportlinker Adds Case Study: Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development
6. Reportlinker Adds R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment
7. Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips
8. Reportlinker Adds Competitor Analysis: Targeted Therapy of Diabetes
9. Reportlinker Adds China Bio-breeding Industry Report, 2010
10. Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other
11. Reportlinker Adds Biomarker Partnering Terms and Agreements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):